Maryam Rasoulinezhad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maryam Rasoulinezhad has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ali Rashidi-Nezhad
Maternal, Fetal and Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Laleh Habibi
Immunology, Asthma, and Allergy Research Institute, Tehran University of Medical Sciences 4 , Tehran
1 shared publication - Mojdeh Mahdiannasser
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Reza Shervin Badv
Pediatric Neurology Division, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- 31 March 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (8) , 7231-7237
CEP104 gene may involve in the pathogenesis of a new developmental disorder other than joubert syndrome
Background The CEP104 gene (OMIM: 616,690) encodes the centrosome protein 104 (CEP104) that is involved in cilia function. Pathogenic variants in this gene have been described in four patients diagnosed with Joubert syndrome (JBTS) 25. Here, we challenged the concept that pathogenic variants in CEP104 gene are only involved in the development of JBTS 25. Methods and results In a clinical setting, whole-exome sequencing (WES) was applied to investigate pathogenic variants in patients with unexplained developmental delay or intellectual disability (DD/ID).WES revealed a novel homozygous nonsense variant (c.643C > T) in CEP104 (NM _014704.3) in a girl with mild intellectual disability, hypotonia, and imbalanced gait. Her brain MRI data did not show molar tooth sign (MTS) or any other brain anomalies. Conclusion Our study introduced a novel variant in the CEP104 gene that results in an ID phenotype other than JBTS25. Comparison of her phenotype with that of eight previously published DD/ID patients harboring pathogenic variants in CEP104 gene revealed that more than half of them did not show JBTS related symptoms. Therefore, we suggest that the CEP104 gene might also be involved in a disorder other than JBTS 25, a point that deserves to be emerged in the OMIM database.
- 31 March 2022
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (8) , 7231-7237
CEP104 gene may involve in the pathogenesis of a new developmental disorder other than joubert syndrome
Background The CEP104 gene (OMIM: 616,690) encodes the centrosome protein 104 (CEP104) that is involved in cilia function. Pathogenic variants in this gene have been described in four patients diagnosed with Joubert syndrome (JBTS) 25. Here, we challenged the concept that pathogenic variants in CEP104 gene are only involved in the development of JBTS 25. Methods and results In a clinical setting, whole-exome sequencing (WES) was applied to investigate pathogenic variants in patients with unexplained developmental delay or intellectual disability (DD/ID).WES revealed a novel homozygous nonsense variant (c.643C > T) in CEP104 (NM _014704.3) in a girl with mild intellectual disability, hypotonia, and imbalanced gait. Her brain MRI data did not show molar tooth sign (MTS) or any other brain anomalies. Conclusion Our study introduced a novel variant in the CEP104 gene that results in an ID phenotype other than JBTS25. Comparison of her phenotype with that of eight previously published DD/ID patients harboring pathogenic variants in CEP104 gene revealed that more than half of them did not show JBTS related symptoms. Therefore, we suggest that the CEP104 gene might also be involved in a disorder other than JBTS 25, a point that deserves to be emerged in the OMIM database.